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ABSTRACT
A cross-sectional study was conducted in 151 (71.6%) of 211 male inmates of a regional Portuguese 
prison in order to establish the seroprevalence for viral hepatitis (HAV, HBV, HCV), human im-
munodeficiency virus (HIV), syphilis and herpes simplex virus (HSV-1 and HSV-2) and to analyze 
some psychosocial and criminal characteristics. Mean age was 34 years. Anti-HAV was positive in 
69.5% (n = 105) and in 34.4% (n = 52) for anti-HCV. One (0.7%) person had HBsAg and 29 (19.2%) 
had laboratory markers of past HBV infection. Non-immune inmates for HBV were 40.4% (n = 61). 
Syphilis was diagnosed in 6.0% (n = 9). The rate of HIV infection was 6.6% (n = 10; all HIV-1). The 
seropositivity of HSV-2 was 19.9% (n = 30) and of HSV-1 was 82.1% (n = 124). Alcohol dependence 
was reported by 26.5% (n = 40). Excluding tobacco and prescription medication, 73.5% (n = 111) 
reported drug use in prison. The most commonly used drugs were: cannabis (100%; n = 111) fol-
lowed by heroin (56.7%; n = 63). Anti-HCV rate was noteworthy. The HIV infection rate (6.6%) in 
this regional prison is at least 13 to 22 times greater than in general population. As the inmate return 
to the community increases the risk of disease exposure for the general population, early detection 
and counseling is urgently needed for prisoners. 
Keywords: mass screening; communicable diseases; prisons; drug users.
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INTRODUCTION
Prison inmates are reported to have higher 
rates of transmissible infectious diseases, 
particularly blood-borne virus and sexually 
transmitted infections (STI) than the gener-
al population. It may be related to risk fac-
tors before incarceration such as low socio-
economic status, poor access to health care, 
poor household sanition, high-risk sexual 
behaviors and injection drug use. Following 
incarceration, additional risk factors, such 
as crowded living conditions, sexual har-
assment, psychological stress, non-profes-
sional tattooing or body piercing, and poor 
ventilation systems contribute to a further 
increase of infectious diseases risk.
The prevalence rate among incarcerated 
individuals is 8-10 times higher for human 
immunodeficiency virus (HIV), 9-10 times 
higher for hepatitis C (HCV), and 4-17 times 
higher for tuberculosis than in the surround-
ing community.1 Men entering prison have 
high risk behavior for STI, including high 
frequencies of injection drug use, needle 
sharing, and unprotected sex with multiple 
and high risk partners. The strong relation-
ship among alcohol and drug use, incarcera-
tion and STI prevalence has been highlight-
ed.2 Drug users are vastly over-represented 
in prison. Moreover, imprisoned popula-
tions are dynamic, with a great deal of fre-
quent in and out of prisoners, prison staff, 
and visitors. These two particularities of 
imprisoned populations, a high proportion 
of drug use and a high turnover of inmates, 
contribute to the spread of blood-borne vi-
ruses among prisoners and the community. 
Since most of blood-borne viruses and/or 
STI (hepatitis B, hepatitis C, HIV, syphilis 
and herpes simplex virus) are asymptomatic, 
there is a need for routine screening. 
The situation regarding HIV and other 
blood-borne and/or STI in prisons in Por-
tugal is unclear as accurate data are limited 
and difficult to access. Therefore, studies 
assessing the real situation of these infec-
tions in the prison environment are urgent-
ly needed. 
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STI education is the most widely used HIV prevention 
intervention in prisons and only a small but increasing 
number of countries provide methadone maintenance pro-
grams, needle and syringe programs, or condoms to pris-
oners. However, entry into the correctional system also of-
fers an important opportunity for primary, secondary and 
tertiary prevention strategies. One should not forget that 
for some detainees, the prison may be the first exposure 
to primary health care. Prison-based screening programs 
provide a unique circumstance for early intervention: for 
the individual through detection and treatment, and 
for the community through interrupting disease transmis-
sion when prisoners return to community. 
The authors conducted a seroepidemiological survey of 
viral hepatitis (hepatitis A-HAV, hepatitis B-HBV and hepati-
tis C-HCV), HIV, syphilis and herpes simplex virus (HSV-1, 
HSV-2) in a male adult regional prison (Regional Prison 
Establishment of Coimbra, Portugal) which has an o! cial 
total number of 220 inmates. This kind of prison is meant for 
prisoners condemned up to 8 years. There is a clinical facil-
ity within the prison with a doctor, nurses and social work-
ers; however the clinical monitoring of infectious diseases is 
carried out in hospitals of the National Health Service. All 
inmates diagnosed with one or more of the previous infec-
tions and without any prior infectious diseases were referred 
to our infectious disease clinic. Unfortunately, this prison 
establishment was closed in June 2009 and all inmates were 
transferred out to other prison facilities. The main reasons 
for this process were related to lack of appropriate condi-
tions such as overcrowding and health facilities. Neverthe-
less, the majority of those referred were kept in our clinic.
METHODS
This cross-sectional study was conducted during Decem-
ber 2007 to January 2008 and March to June 2008. All par-
ticipants signed an informed consent and provided a blood 
sample. All epidemiological and demographic data were 
collected through an interview performed by a psychologist 
and a medical doctor. The following serological techniques 
were used: CMIA (chemiluminescent microparticle immu-
noassay) for viral hepatitis and HIV; RPR (rapid plasma re-
agin) and TPPA (Treponema pallidum particle agglutination 
assay) for syphilis and ELISA (enzyme-linked immunosorb-
ent assay) for HSV. HIV positive serology was always con-
firmed by Western blot.
RESULTS
All prisoners were asked to take part in the study. During the 
first period, 121 from 146 inmates accepted to be screened 
and during the second period, from 65 inmates that were not 
imprisoned in the first period, 30 entered the study. There-
fore, 151 (71.6%) of 211 inmates participated in this survey. 
Table 1. Demographic characteristics of the study 
sample
Characteristics n = 151 %
Age, mean (SD),  34.1 (10.8), [19-75] 
[min, max] 
Ethnicity 
 White 92 60.9% 
 Black 59 39.0%
Marital status 
 Single  86 57.0% 
 Divorced  44 29.1% 
 Married  8 5.3% 
 Widowed  13 8.6%
Education level 
 Illiteracy  18 11.9% 
 Elementary  69 45.7% 
 High school  55 36.4% 
 Vocational  9 6.0%
The socio-demographic profile, shown in Table 1, 
revealed a mean age of 34 years ranging from 19 and 
75 years; 60.9% were Caucasian, 57% were single and 45.7% 
had elementary education.
The majority (71.5%; n = 108) of the inmates had a his-
tory of previous incarceration and their crime typology 
was as follows: assault with intent to endanger life (n = 10), 
attempted kidnapping and burglary (n = 1), the!  (n = 20); 
criminal fraud (n = 2), drug tra! c (n = 78) and driving un-
der the influence of alcohol (n = 40).
Most of the inmates admitted substance dependency of 
cannabis (n = 111; 73.5%), heroin – a semi-synthetic opiate 
(n = 63; 41.7%), alcohol (n = 40; 26.5%) and methadone – a 
fully synthetic opioid (n = 19; 12.6%). Tobacco and prescrip-
tion medication were not considered. Regarding illicit drug 
use in prison, cannabis and/or heroin were the only drugs 
reported by 73.5% (n = 111) of inmates. The drug use pat-
tern before and a! er incarceration is shown in Table 2. 
Although there were no cases of new onset of drug ad-
diction a! er detention, the pattern of drug use changed 
while in prison. Above all, heroin use increased with reclu-
sion, but all heroin addicts denied its injection use in prison.
Regarding sexual behavior, there was an almost unani-
mous preponderance of heterosexual sexual orientation 
(98.7%; n = 149), except for two that did not respond. Be-
fore incarceration, 75.5% (n = 114) had multiple sex partners 
and the frequency of condom use was as follows: frequent-
ly (3.3%; n = 5), rarely (30.5%; n = 46) and never (66.2%; 
n = 100). When questioned about condom use during reclu-
sion, all inmates replied that they have not had sex with anyone. 
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A! er imprisonment, 43.0% (n = 65) reported receiving 
a tattoo and 3.3% (n = 5) a piercing.
The serological testing revealed the following results:
HCV infection: The overall anti-HCV prevalence was 
34.4% (n = 52), which was noteworthy.
Concerning HBV serological testing, three serostatus 
categories were established: past infection, all with anti-
HBc-positive (includes people who were infected in the 
past and have either anti-HBc positive plus anti-HBs posi-
tive or isolated anti-HBc positive), chronic infection (anti-
HBc-positive and HBsAg-positive) and no immunity (an-
ti-HBc-negative, anti-HBs-negative and HBsAg-negative). 
Therefore, HBV serostatus were as follows: past infection 
(19.2%; n = 29), chronic infection (0.7%; n = 1) and no im-
munity (40.4%; n = 61). Serological evidence of vaccination 
was present in 39.7% (n = 60).
HAV immunity was observed in 69.5% (n = 105) of 
inmates.
HIV infection: Anti-HIV prevalence was 6.6% (n = 10), 
all HIV-1 positive. The majority (80%; n = 8) were co-infect-
ed with HCV.
Syphilis: This STI was diagnosed in 6.0% (n = 9), all with 
latent syphilis. 
HSV infection: Genital HSV infection is life-long with 
rare to frequent recurrences of symptomatic and asympto-
matic genital shedding of 2 serotypes of virus; most com-
monly HSV-2, and sometimes HSV-1. The seropositivity of 
HSV-2 was 19.9% (n = 30) and of HSV-1, 82.1% (n = 124). 
None of the inmates had active genital lesions.
DISCUSSION
Because of the absence of a vaccine, further reductions in the 
number of new HCV cases will depend on harm reduction 
education. HCV prevalence is comparable to that among 
other prison populations in Portugal, Spain and USA.3-6 
Nevertheless, it is 17 to 23 times higher than the Portuguese 
general population (1.5%-2.0%).
Vaccination for HAV and HBV should be o! ered to 
all non-immunes, although vaccination coverage for HBV 
(39.7%) was adequate as well as the immunization rate for 
HAV (69.5%). Concerning the latter, most of incarcerated 
persons have risk factors for infection (drug use, homosex-
ual sex); for that reason vaccination is essential for prevent-
ing acute hepatitis A outbreaks in prisons. In this study, the 
immunization rate for HAV, either natural or by vaccina-
tion, is one of the highest in prison settings. The prevalence 
of prior HAV infection among USA incarcerated persons 
is estimated at 22%-39%.6 Chronic HBV infection preva-
lence (0.7%) in this survey was slightly lower than the one 
described among USA prison inmates (1.0%-3.7%).6 Stud-
ies have shown that achieving high vaccination coverage is 
both feasible and cost-e! ective and treating appropriately 
screened individuals has been considered a reasonable ex-
penditure for correctional facilities.7
Portugal has the second highest HIV incidence rate 
(251.1 cases per million inhabitants) within the context of 
the 52 European countries.8 HIV infection rate (6.6%) in 
Coimbra Regional Prison is at least 13 to 22 times greater 
Table 2. Patterns of illicit drug use
Drug use: illicit drugs   n = 111 (73.5%) %
Age at the beginning of consumption, mean [min, max]   15, [12-24]
Type of drug (n = 111)                   Before incarceration                   After incarceration 
 Cannabis  92 82.9% 111 100% 
 Heroin 14 12.6% 63 56.7% 
 Others 5 4.5% 0 0%
Setting of drug use (before incarceration) 
 Social 87  78.4% 
 Familiar 20  18.0% 
 Alone  4  3.6%
Route of heroin administration in prison (n = 63) 
 Smoking  16  25.3% 
 Sniffing/Snorting  47  74.6%
Frequency of heroin administration in prison (n = 63) 
 Weekly  27  42.9% 
 Monthly  9  14.3% 
 Daily  18  28.6% 
 No response 9 14.3% 
Screening for infectious diseases in prisons
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than in the Portuguese general population (0.3%-0.5%). It is 
similar to the prevalence found in some of the French pris-
ons (6%) and lower than the rates reported in the USA (up to 
17% for prisons in New York) and Spain (19%) correctional 
facilities.4,5,9,10 Nonetheless, in the USA, HIV seroprevalence 
among prisoners was 1.1%-1.9% in 2003.11 According to the 
National Program for Prevention and Control of HIV/AIDS 
infection, it is estimated that the prevalence of HIV infection 
in the incarcerated Portuguese population is 10.2% and the 
HCV infection rate is 29%, with 56.8% of HIV-infected in-
mates co-infected by HCV.8 Being diagnosed with a sexually 
transmitted disease puts a person at increased risk for con-
tracting HIV and serves as an indicator of HIV risk behav-
ior. Therefore, the rate of syphilis (6.0%), similar to HIV rate, 
is significant as well as the high prevalence of seropositivity 
for HSV. The medical literature reports an increased risk of 
HIV acquisition estimated at 2 to 4 times greater when HSV 
is present, particularly in men who have sex with men.12 
In the USA, the rate of syphilis diagnosed in male prison 
inmates, during 2004, was 2.7%, lower than the rate found in 
our study.13 To our knowledge, studies concerning seroprev-
alence of HSV infection in prison are scarce. Seropositiv-
ity of HSV-2 was 19.9%, which is important since HSV-2 is 
the primary cause of genital herpes, transmitted primarily 
through sexual contact.
Sexual risk behavior compounded by addictive problems 
such as alcoholism or drug abuse is frequent and increases 
with incarceration. Heroin use increased 4.5 times with im-
prisonment. The report of no drug injecting observed in this 
study may be related to some particularities of this kind of 
establishment. Besides being a prison with short capacity, 
due to a punishment and violence dynamic, inmates may 
su! er retaliations if syringes or other injecting parapherna-
lia are found in their cells, which are being constantly super-
vised by prison guards. Additionally, it is reported that in-
travenous drug users are more likely to stop injecting than 
to continue while in prison.14 Approximately one in four 
injectors reported continuing to inject drugs while in 
prison inthe UK.14,15 A high prevalence (43%) of tattooing 
in prison was found. Tattooing may provide a link between 
non-injecting and injecting inmates, thus enabling blood-
borne infections to be disseminated. Furthermore, it is 
well-known that addictive behavior is associated to crime 
with high relapse rates. Drug use implies alteration of con-
sciousness and a self-perception of loss of control. Most of 
the inmates also had high prevalence of sexual risk behavior, 
particularly sexual intercourse without condoms and mul-
tiple sex partners. Although they unanimously have denied 
having sex in prison, condoms should be supplied to them. 
This epidemiological study represents a disturbing reality 
and is a public health issue. Over 70% of the prison inmates 
had been previously incarcerated illustrating the close tie 
between civilian and incarcerated populations.
As the inmate return to the community increases the risk 
of disease exposure for the general population, early detec-
tion and counseling is urgently needed for prisoners. We 
must act to change behaviors through cognitive and emo-
tional instruments and consider skills, personality traits and 
social support.
E! ective health promotion requires both human and fi-
nancial investment in the field of public health. Correctional 
facility-based immunization programs, infectious disease 
screening and treatment, and harm-reduction e! orts are es-
sential components of any strategy for the control of com-
municable diseases. 
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